Secondary ALL after Successful Treatment of Ewing's Sarcoma: A Case Report

Treatment with intensification of chemotherapy using alkylating agents and Topoisomerase II inhibitors and radiotherapy has improved the outcome of patients with solid tumors such as Ewing’s sarcoma. However, there are several reports of secondary malignancy following treatment of these tumors. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goudarzi Pour, Kourosh, Alavi, Samin, Shamsian, Shahin, Aghakhani, Roxana, Arzanian, Mohammad Taghi, Hoseini Tavassol, Hesameddin, Eydian, Zahra, Kazemi, Reyhaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139944/
https://www.ncbi.nlm.nih.gov/pubmed/27928479
Descripción
Sumario:Treatment with intensification of chemotherapy using alkylating agents and Topoisomerase II inhibitors and radiotherapy has improved the outcome of patients with solid tumors such as Ewing’s sarcoma. However, there are several reports of secondary malignancy following treatment of these tumors. In this article, we describe a 12 years old girl with ALL who had Ewing’s sarcoma when she was 8 years old and underwent successful treatment but after two and half years at 12 years old, she came back with pallor and muscular pain.

Ejemplares similares